PGEN.NASDAQPrecigen, INC

Form 4: Precigen Executive Sells Shares for Tax Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reported the sale of 29,131 shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.

Summary

  • Donald P. Lehr, Chief Legal Officer of Precigen, Inc., sold 29,131 shares of common stock.
  • The transaction occurred on May 28, 2026, and was a 'sell-to-cover' to satisfy tax withholding obligations.
  • These obligations arose from the vesting of restricted stock units on May 23, 2026.
  • The sale price was $4.36 per share.
  • Following this transaction, Mr. Lehr beneficially owns 755,461 shares of Precigen common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves a stock sale by an executive, the reason is a standard tax withholding event, not necessarily indicative of a negative view on the company's prospects.

Negatives

  • A significant number of shares were sold by a key executive, which could be perceived negatively by the market, although it was for tax purposes.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership by an executive.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors regarding their stock transactions. While any sale of stock by an insider can attract attention, this specific transaction is identified as a 'sell-to-cover' for tax obligations, which is a common and often necessary event upon the vesting of equity awards.

Stakeholder Impact

  • Shareholders: May observe the sale of shares by an executive, but the 'sell-to-cover' nature for tax purposes mitigates concerns about insider confidence.

Key Dates

DateDescription
05/23/2026Vesting of restricted stock units.
05/28/2026Date of stock sale transaction.
06/01/2026Date of signature on the filing.

Keywords

Precigen, PGEN, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.